Late-onset hypogonadism: Beyond testosterone

Asian Journal of Andrology

Volumn 17, Issue 2, 2015, Pages 236-238

  Foresta, Carlo ^a   Calogero, Aldo E ^b   Lombardo, Francesco ^c   Lenzi, Andrea ^c   Ferlin, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

insulin like factor 3; late onset hypogonadism; male hypogonadism; testosterone; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIDIOL; COLECALCIFEROL; PARATHYROID HORMONE; UNCLASSIFIED DRUG; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; CALCIFEDIOL; LUTEINIZING HORMONE; TESTOSTERONE; VITAMIN D;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; AGING; ANALOGS AND DERIVATIVES; BLOOD; DEFICIENCY; EUNUCHISM; METABOLISM; PERSONALIZED MEDICINE;

ADULT; AGING; BIOMARKERS; CALCIFEDIOL; CHOLECALCIFEROL; EUNUCHISM; HUMANS; LUTEINIZING HORMONE; MALE; PARATHYROID HORMONE; PRECISION MEDICINE; TESTOSTERONE; TREATMENT OUTCOME; VITAMIN D;

EID: 84924664584     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.135985     Document Type: Article

References (18)

1. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536-59.
2. Ferlin A, Selice R, Carraro U, Foresta C. Testicular function and bone metabolism - beyond testosterone. Nat Rev Endocrinol 2013; 9: 548-54.
3. Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 2010; 95: 1810-8.
4. Hyde Z, Norman PE, Flicker L, Hankey GJ, McCaul KA, et al. Elevated LH predicts ischaemic heart disease events in older men: the health in men study. Eur J Endocrinol 2011; 164: 569-77.
5. Hyde Z, Norman PE, Flicker L, Hankey GJ, Almeida OP, et al. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the health in men study. J Clin Endocrinol Metab 2012; 97: 179-89.
6. Brandi ML, Minisola S. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent. Curr Med Res Opin 2013; 29: 1565-72.
7. Foresta C, Strapazzon G, De Toni L, Perilli L, Di Mambro A, et al. Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis. J Clin Endocrinol Metab 2011; 96: E646-52.
8. Foresta C, Selice R, De Toni L, Di Mambro A, Carraro U, et al. Altered bone status in unilateral testicular cancer survivors: role of CYP2R1 and its luteinizing hormone-dependency. J Endocrinol Invest 2013; 36: 379-84.
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
10. Cianferotti L, Marcocci C. Subclinical vitamin D deficiency. Best Pract Res Clin Endocrinol Metab 2012; 26: 523-37.
11. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363: 123-35.
12. Pye SR, Huhtaniemi IT, Finn JD, Lee DM, O'Neill TW, et al. Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab 2014; 99: 1357-66.
13. Lerchbaum E, Pilz S, Boehm BO, Grammer TB, Obermayer-Pietsch B, et al. Combination of low free testosterone and low vitamin D predicts mortality in older men referred for coronary angiography. Clin Endocrinol (Oxf) 2012; 77: 475-83.
14. Holm AC, Fredrikson MG, Theodorsson E, Palmefors LG, Karlsson PS, et al. Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism. Aging Male 2011; 14: 249-56.
15. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002; 87: 589-98.
16. Haring R, Xanthakis V, Coviello A, Sullivan L, Bhasin S, et al. Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study. Int J Androl 2012; 35: 775-82.
17. Camacho EM, Huhtaniemi IT, O'Neill TW, Finn JD, Pye SR, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol 2013; 168: 445-55.
18. Huhtaniemi I. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl 2014; 16: 192-202.